MALARIA, CEREBRAL, SUSCEPTIBILITY TO (finding)
|
disease |
|
Finding
|
1
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
0.961 |
102 |
2
|
1989 |
2019 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.100 |
None |
1.000 |
51 |
|
1989 |
2019 |
melanoma
|
disease |
Neoplasms
|
Neoplastic Process
|
3087
|
515
|
0.100 |
None |
0.912 |
34 |
|
1989 |
2019 |
Carcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2462
|
103
|
0.020 |
None |
1.000 |
2 |
|
1989 |
1998 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.100 |
None |
0.971 |
35 |
2
|
1990 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.100 |
None |
1.000 |
32 |
2
|
1990 |
2019 |
Rhinovirus infection
|
disease |
Infections
|
Disease or Syndrome
|
202
|
4
|
0.100 |
None |
1.000 |
22 |
|
1990 |
2019 |
Systemic Scleroderma
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
979
|
287
|
0.090 |
None |
1.000 |
9 |
|
1990 |
2018 |
Glioblastoma Multiforme
|
disease |
Neoplasms
|
Neoplastic Process
|
3197
|
186
|
0.080 |
None |
1.000 |
8 |
|
1990 |
2019 |
Leukemia, Myelocytic, Acute
|
disease |
Neoplasms
|
Neoplastic Process
|
3111
|
6892
|
0.060 |
None |
1.000 |
6 |
|
1990 |
2015 |
Glioblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
3177
|
281
|
0.050 |
None |
1.000 |
5 |
1
|
1990 |
2018 |
Childhood Glioblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2527
|
98
|
0.050 |
None |
1.000 |
5 |
|
1990 |
2018 |
Adult Glioblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2528
|
98
|
0.050 |
None |
1.000 |
5 |
|
1990 |
2018 |
Synovitis
|
disease |
Musculoskeletal Diseases
|
Disease or Syndrome
|
197
|
|
0.040 |
None |
1.000 |
4 |
|
1990 |
2019 |
Scleroderma
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
316
|
5
|
0.030 |
None |
1.000 |
3 |
|
1990 |
2006 |
Blast Phase
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
299
|
14
|
0.010 |
None |
1.000 |
1 |
|
1990 |
1990 |
Prolymphocytic Leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
37
|
2
|
0.010 |
None |
1.000 |
1 |
|
1990 |
1990 |
Lymphoproliferative Disorders
|
group |
Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
300
|
14
|
0.010 |
None |
1.000 |
1 |
|
1990 |
1990 |
Myeloid Leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
385
|
7
|
0.010 |
None |
1.000 |
1 |
|
1990 |
1990 |
Hematologic Neoplasms
|
group |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
827
|
60
|
0.010 |
None |
1.000 |
1 |
|
1990 |
1990 |
Secondary Neoplasm
|
group |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2492
|
85
|
0.100 |
None |
1.000 |
15 |
|
1991 |
2019 |
Carcinoma of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
4081
|
1204
|
0.100 |
None |
1.000 |
11 |
|
1991 |
2018 |
Leprosy, Lepromatous
|
disease |
Infections
|
Disease or Syndrome
|
94
|
17
|
0.020 |
None |
0.500 |
2 |
|
1991 |
2017 |
Glomerulonephritis
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
391
|
7
|
0.020 |
None |
1.000 |
2 |
|
1991 |
2008 |